# Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites

> **NCT01512017** · PHASE3 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 96 (actual)

## Conditions studied

- Split-thickness Skin Graft Donor Sites

## Interventions

- **DEVICE:** Crystalline cellulose simple occlusive dressing
- **DEVICE:** Vaseline

## Key facts

- **NCT ID:** NCT01512017
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2012-01-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01512017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01512017, "Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01512017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*